New Chemoselective Method Creates Chiral Stapled Peptides for Protein Interaction Drugs
A facile chemoselective modification of thioethers generates chiral centers within stapled peptides, enabling study of how secondary conformation affects biophysical properties for protein-protein interaction drug design.
Quick Facts
What This Study Found
Facile chemoselective thioether modification generates chiral center-containing stapled peptides, enabling direct study of how secondary conformation affects biophysical properties of peptide PPI inhibitors.
Key Numbers
R-configuration chiral center; thioether, sulfoxide, sulfonium systems; enhanced helicity, stability, cell penetration
How They Did This
Synthetic chemistry study. Chemoselective modification of thioether linkages in stapled peptides. Chiral center generation. Conformational analysis. Biophysical property characterization.
Why This Research Matters
Understanding how peptide shape affects drug properties enables more rational design. Chiral stapled peptide pairs provide the first controlled way to study this — potentially doubling the design options for stapled peptide drugs.
The Bigger Picture
Chirality in stapled peptides is an underexplored design dimension. This methodology opens a new axis for optimizing stapled peptide drugs by systematically evaluating how stereochemistry affects target binding.
What This Study Doesn't Tell Us
Chemistry methodology study. Biological activity comparisons of chiral peptide pairs not extensively characterized. Limited to thioether-stapled peptides.
Questions This Raises
- ?Do different chiral forms of the same stapled peptide have different biological activities?
- ?Can this method be applied to existing clinical-stage stapled peptides?
- ?Does chirality affect stapled peptide cell permeability?
Trust & Context
- Key Stat:
- New design dimension Chirality in stapled peptides is largely unexplored — this simple chemistry creates matched chiral pairs for direct comparison of how shape affects drug properties
- Evidence Grade:
- Low evidence grade: synthetic methodology development.
- Study Age:
- Published 2021. Stapled peptide design continues advancing with new chemical modifications.
- Original Title:
- Facile Chemoselective Modification of Thioethers Generates Chiral Center-Induced Helical Peptides.
- Published In:
- Methods in molecular biology (Clifton, N.J.), 2355, 301-322 (2021)
- Authors:
- Liu, Yinghuan, Hu, Kuan(2), Yin, Feng(5), Li, Zigang
- Database ID:
- RPEP-05563
Evidence Hierarchy
Frequently Asked Questions
What is chirality in peptides?
Chirality means a molecule and its mirror image are not identical (like left and right hands). In stapled peptides, the staple can create new chiral centers that make two forms of the same peptide with potentially different biological activities.
Why does shape matter for peptide drugs?
Peptide drugs must fit precisely into their target protein's surface. Even subtle 3D shape changes from chirality can dramatically affect binding, cell entry, and stability — making chirality an important but underexplored design parameter.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05563APA
Liu, Yinghuan; Hu, Kuan; Yin, Feng; Li, Zigang. (2021). Facile Chemoselective Modification of Thioethers Generates Chiral Center-Induced Helical Peptides.. Methods in molecular biology (Clifton, N.J.), 2355, 301-322. https://doi.org/10.1007/978-1-0716-1617-8_23
MLA
Liu, Yinghuan, et al. "Facile Chemoselective Modification of Thioethers Generates Chiral Center-Induced Helical Peptides.." Methods in molecular biology (Clifton, 2021. https://doi.org/10.1007/978-1-0716-1617-8_23
RethinkPeptides
RethinkPeptides Research Database. "Facile Chemoselective Modification of Thioethers Generates C..." RPEP-05563. Retrieved from https://rethinkpeptides.com/research/liu-2021-facile-chemoselective-modification-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.